Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for HLF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 32.90M
March 31, 2026 113.80M
December 31, 2025 98.30M
September 30, 2025 138.80M
June 30, 2025 96.00M
March 31, 2025 0.20M
December 31, 2024 69.60M
September 30, 2024 99.50M
June 30, 2024 102.50M
March 31, 2024 13.80M
December 31, 2023 96.10M
September 30, 2023 79.60M
June 30, 2023 135.60M
March 31, 2023 46.20M
December 31, 2022 53.60M
September 30, 2022 69.60M
June 30, 2022 98.80M
March 31, 2022 130.50M
December 31, 2021 85.40M
September 30, 2021 88.00M
June 30, 2021 176.80M
March 31, 2021 110.10M
December 31, 2020 112.50M
September 30, 2020 131.10M
June 30, 2020 243.30M
Date Value
March 31, 2020 141.70M
December 31, 2019 156.60M
September 30, 2019 186.10M
June 30, 2019 76.30M
March 31, 2019 38.50M
December 31, 2018 138.70M
September 30, 2018 164.80M
June 30, 2018 188.70M
March 31, 2018 156.20M
December 31, 2017 186.40M
September 30, 2017 127.30M
June 30, 2017 101.60M
March 31, 2017 175.50M
December 31, 2016 117.40M
September 30, 2016 -118.10M
June 30, 2016 226.90M
March 31, 2016 141.10M
December 31, 2015 135.50M
September 30, 2015 134.50M
June 30, 2015 197.60M
March 31, 2015 161.10M
December 31, 2014 61.90M
September 30, 2014 101.91M
June 30, 2014 156.93M
March 31, 2014 190.65M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Nu Skin Enterprises, Inc. 10.62M
Joey New York, Inc. --
Merion, Inc. --
Warpaint London Plc --
USANA Health Sciences, Inc. 23.32M